BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10512629)

  • 1. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
    Borchers C; Tomer KB
    Biochemistry; 1999 Sep; 38(36):11734-40. PubMed ID: 10512629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the tertiary structure of soluble CD4 bound to glycosylated full-length HIVgp120 by chemical modification of arginine residues and mass spectrometric analysis.
    Hager-Braun C; Tomer KB
    Biochemistry; 2002 Feb; 41(6):1759-66. PubMed ID: 11827520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
    Moore JP; McKeating JA; Huang YX; Ashkenazi A; Ho DD
    J Virol; 1992 Jan; 66(1):235-43. PubMed ID: 1727487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.
    Dey B; Del Castillo CS; Berger EA
    J Virol; 2003 Mar; 77(5):2859-65. PubMed ID: 12584309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
    Peakman M; Senaldi G; Foote N; McManus TJ; Vergani D
    J Infect Dis; 1992 May; 165(5):799-804. PubMed ID: 1349032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
    Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
    J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Moore JP; McKeating JA; Weiss RA; Sattentau QJ
    Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.
    Chamow SM; Kogan TP; Peers DH; Hastings RC; Byrn RA; Ashkenazi A
    J Biol Chem; 1992 Aug; 267(22):15916-22. PubMed ID: 1639820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.
    Fu YK; Hart TK; Jonak ZL; Bugelski PJ
    J Virol; 1993 Jul; 67(7):3818-25. PubMed ID: 8510207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor.
    Malvoisin E; Wild F
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():839-47. PubMed ID: 8151300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific.
    Ashish ; Juncadella IJ; Garg R; Boone CD; Anguita J; Krueger JK
    J Biol Chem; 2008 Feb; 283(5):2761-72. PubMed ID: 18045872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.
    Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
    AIDS; 1992 Mar; 6(3):249-56. PubMed ID: 1348943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
    Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
    Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.